EquityZen Growth Technology Fund LLC - Series 1322
Raised
$248K
Investors
15
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1322 is a Delaware pooled investment fund that raised $248K from 15 investors with a $10K minimum investment, filed October 5, 2022. The vehicle claims exemptions under Rule 506(b) and Section 3(c)(1) and is managed by EquityZen Advisors, part of the EquityZen platform specializing in pre-IPO secondary market access with 1,889 related EDGAR entities.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption pattern common to private fund structures targeting accredited investors. The $10K minimum investment represents a relatively accessible entry point compared to institutional pre-IPO vehicles, consistent with EquityZen's retail-oriented platform model for secondary market shares in private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
